3-(2-Cyclopropoxyquinolin-6-yl)-1-((3-methyloxetan-3-yl)-methyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

ID: ALA4556402

Chembl Id: CHEMBL4556402

PubChem CID: 122442410

Max Phase: Preclinical

Molecular Formula: C22H22N6O2

Molecular Weight: 402.46

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CC1(Cn2nc(-c3ccc4nc(OC5CC5)ccc4c3)c3c(N)ncnc32)COC1

Standard InChI:  InChI=1S/C22H22N6O2/c1-22(10-29-11-22)9-28-21-18(20(23)24-12-25-21)19(27-28)14-2-6-16-13(8-14)3-7-17(26-16)30-15-4-5-15/h2-3,6-8,12,15H,4-5,9-11H2,1H3,(H2,23,24,25)

Standard InChI Key:  KFKFVECNWPOOGT-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA4556402

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 402.46

Molecular Weight (Monoisotopic): 402.1804

AlogP: 3.20

#Rotatable Bonds: 5

Polar Surface Area: 100.97

Molecular Species: NEUTRAL

HBA: 8

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 8

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 3.75

CX LogP: 2.95

CX LogD: 2.94

Aromatic Rings: 4

Heavy Atoms: 30

QED Weighted: 0.55

Np Likeness Score: -0.65

References

1. Vidadala RS, Rivas KL, Ojo KK, Hulverson MA, Zambriski JA, Bruzual I, Schultz TL, Huang W, Zhang Z, Scheele S, DeRocher AE, Choi R, Barrett LK, Siddaramaiah LK, Hol WG, Fan E, Merritt EA, Parsons M, Freiberg G, Marsh K, Kempf DJ, Carruthers VB, Isoherranen N, Doggett JS, Van Voorhis WC, Maly DJ..  (2016)  Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis.,  59  (13): [PMID:27309760] [10.1021/acs.jmedchem.6b00760]

Source

Source(1):

• Scientific Literature